Accelera Innovations

Accelera Innovations Net Debt / EBITDA

The Net Debt to EBITDA of Accelera Innovations (ACNV) as of Nov 16, 2026 is -0.55. In the previous year, Net Debt to EBITDA was -0.38 — a change of 44.24% (lower).

Net Debt / EBITDA

-0.55

YoY

44.24%

Last updated:

Net Debt to EBITDA of Accelera Innovations is 2016 -0.55 . Net Debt to EBITDA of Accelera Innovations was 2015 -0.38 . It decreases by 44.24% lower compared to the previous year.

The Accelera Innovations Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2013
-0.80 USD
Jan 1, 2014
-0.17 USD
Jan 1, 2015
-0.38 USD
Jan 1, 2016
-0.55 USD
The Accelera Innovations Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
-0.55+44.24%
-0.38+126.35%
-0.17-78.94%
-0.80—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accelera Innovations Stock analysis

What does Accelera Innovations do? Accelera Innovations, Inc. generates revenue through its subsidiary SCI Home Health, Inc., operating as Advance Lifecare Home Health, which provides personal care services to patients in the Chicago, Illinois area. The company focuses on acquiring businesses in the post-acute care patient services and information technology services sectors, with SCI Home Health representing its primary healthcare service offering. Revenue is derived from healthcare service contracts within the post-acute care segment, targeting patients requiring ongoing care after hospitalization. The company's business model centers on strategic acquisitions within the healthcare services industry, specifically targeting post-acute care providers and technology service firms. SCI Home Health, Inc. serves as the operational vehicle for delivering personal care services, while the company's acquisition strategy aims to expand its presence in the healthcare sector through targeted investments in complementary businesses. The firm's revenue streams are primarily tied to the delivery of home health services under the Advance Lifecare Home Health brand in the Chicago metropolitan area. Accelera Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accelera Innovations stock

Net Debt to EBITDA of Accelera Innovations is -0.55 in 2016.

Net Debt to EBITDA of Accelera Innovations changed from -0.38 to -0.55, representing a 44.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Accelera Innovations since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Accelera Innovations with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Accelera Innovations

All Key Metrics — Accelera Innovations